BackEloxx Pharmaceuticals Overview

Eloxx Pharmaceuticals Operating Income

Operating Income for ELOX.

Quarterly Operating Income

$-3795000.00

As of Mar 31, 2026

Annual Operating Income (TTM)

$-17055000.00
50.45% YoY

Trailing 12 months ending Mar 31, 2026

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)